Making Study Populations Visible through Knowledge Graphs

A website to navigate resources open-sourced via the associated ISWC 2019 paper



*This image was taken from: https://www.policyschool.ca/background-banner/health-policy/health-banner/

List of Research Studies Utilized

Pharmacologic Approaches to Glycemic Treatment (Chapter 8)

  1. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
  2. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
  3. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets
  4. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
  5. Glycaemic control and hypoglycaemia with new insulin glargine300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
  6. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
  7. Safety and effectiveness of biphasic insulin aspart 30 in people with type 2 diabetes switching from basal-bolus insulin regimens in the A1chieve study
  8. Cardiovascular Disease and Risk Management (Chapter 9)

  9. Effects of intensive blood-pressure control in type 2 diabetes mellitus
  10. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
  11. Cardiovascular Outcomes Using Doxazosin vs. Chlorthalidone for the Treatment of Hypertension in Older Adults With and Without Glucose Disorders: A Report From the ALLHAT Study
  12. Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
  13. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes
  14. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
  15. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet
  16. Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
  17. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial
  18. A randomized controlled study of Finerenone vs. Eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
  19. Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
  20. Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
  21. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentrer andomised placebo-controlled trial

NHANES Patient Records

Gender Age Ethnicity Race Body Mass Index (BMI) Systolic Blood Pressure (SBP) Diastolic Blood Pressure (DBP) HemoglobinA1C (HbA1C)
Male 55 NonHispanic African American 26.53 106 72.67 5.2
Female 44 NonHispanic African American 30.9 139.33 73.34 6
Male 70 NonHispanic White 24.74 130.67 57.34 7.1
Female 16 NonHispanic African American 16.79 118.67 50.67 4.7
Male 73 NonHispanic White 30.63 120 67.34 5.9
Female 14 NonHispanic African American 34.5 114 77.34 8